Bioterrorism WORLD OF MICROBIOLOGY AND IMMUNOLOGY
76
•
mal bioweapons programs in 1969—unintended byproducts or
deliberate misuse of emerging technologies offer potential
bioterrorists opportunities to prepare or refine biogenic
weapons. Genetic engineering technologies can be used to
produce a wide variety of bioweapons, including organisms
that produce toxins or that are more weaponizable because
they are easier to aerosolize (suspend as droplets in the air).
More conventional laboratory technologies can also produce
organisms resistant to antibiotics, routine vaccines, and thera-
peutics. Both technologies can produce organisms that cannot
be detected by antibody-based sensor systems.
Among the most serious of potential bioterrorist
weapons are those that use smallpox(caused by the Variola
virus), anthrax(caused by Bacillus anthracis), and plague
(caused by Yersinia pestis). During naturally occurring epi-
demicsthroughout the ages, these organisms have killed sig-
nificant portions of afflicted populations. With the advent of
vaccines and antibiotics, few U.S. physicians now have the
experience to readily recognize these diseases, any of which
could cause catastrophic numbers of deaths.
Although the last case of smallpox was reported in
Somalia in 1977, experts suspect that smallpox virusesmay be
in the biowarfare laboratories of many nations around the
world. At present, only two facilities—one in the United
States and one in Russia—are authorized to store the virus. As
recently as 1992, United States intelligence agencies learned
that Russia had the ability to launch missiles containing
weapons-grade smallpox at major cities in the U.S. A number
of terrorist organizations—including the radical Islamist Al
Qaeda terrorist organization—actively seek the acquisition of
state-sponsored research into weapons technology and
pathogens.
There are many reasons behind the spread of biowar-
fare technology. Prominent among them are economic incen-
tives; some governments may resort to selling bits of
scientific information that can be pieced together by the buyer
to create biological weapons. In addition, scientists in politi-
cally repressive or unstable countries may be forced to par-
ticipate in research that eventually ends up in the hands of
terrorists.
A biological weapon may ultimately prove more power-
ful than a conventional weapon because its effects can be far-
reaching and uncontrollable. In 1979, after an accident
involving B. anthracisin the Soviet Union, doctors reported
civilians dying of anthrax pneumonia (i.e., inhalation
anthrax). Death from anthrax pneumonia is usually swift. The
bacilli multiply rapidly and produce a toxin that causes breath-
ing to stop. While antibiotics can combat this bacillus, sup-
plies adequate to meet the treatment needs following an attack
on a large urban population would need to be delivered and
A decontamination crew responds to a possible release of anthrax by terrorists at a United States postal facility in 2001.
womi_B 5/6/03 1:10 PM Page 76